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Abstract
Introduction—The limited research on the management of aneurysmal subarachnoid hemorrhages
(aSAHs) has not assessed the efficacy of neurology-led care. Our objective was to describe aSAH patients’
outcomes after transitioning from a neurosurgery-led intensive care unit (ICU) to a neurology-led multidis‐
ciplinary care neurocritical care unit (NCCU). The study hypothesis was that the neurology-led multidisci‐
plinary care would improve patient outcomes.
Methods—This was a retrospective cohort study. We included patients (≥ 18) with aSAHs from 1/16 to
8/16 (pregroup) and from 3/17 to 11/17 (postgroup). The pregroup care was led by a neurosurgeon. The
postgroup care included a neurologist, a pulmonary intensivist, a neurocritical care clinical nurse specialist,
a neurosurgeon, and euvolemia protocol. The primary outcome was trips to interventional radiology (IR)
for vasospasm treatment. Univariate analyses and multivariable ordinal logistic regression were used.
Results—There were 99 patients included: 50 in the pregroup and 49 in the postgroup. On average, post‐
group patients were 7 years older than the pregroup (p = 0.05); no other demographic or clinical character‐
istics significantly differed. The odds were 62% lower that the postgroup had a higher number of trips to IR
for vasospasm treatment, when compared to the pregroup, p < 0.001.
Conclusions—In aSAH patients, the neurology-led multidisciplinary care in the NCCU decreased the
odds of repeated procedures for vasospasm treatment. Neurology-led multidisciplinary care could be more
cost-effective than the neurosurgical-led care.
 
INTRODUCTION
The limited research on aneurysmal subarachnoid hem‐
orrhage (aSAH) management assessed the efficacy of
neurointensivist-led multidisciplinary care on patient
outcomes when compared to neurosurgical- or neurol‐
ogy and neurosurgical-led care [1–3]. In these studies,
outcomes included length of stay (LOS), discharge dis‐
position, mortality, ventriculoperitoneal (VP) shunt
placement, ventilator-acquired pneumonia, and delayed
cerebral ischemia (DCI). No studies compared the num‐
ber of trips to interventional radiology (IR) for vaso‐
spasm treatment in aSAH patients by management type.
Up to 70% of aSAH patients develop vasospasm,
defined as cerebral artery narrowing on angiography,
typically between 4 and 14 days after an aneurysm rup‐
tures [4–6]. In aSAH patients, DCI from vasospasm
remains the greatest cause of death [7]. Endovascular
rescue treatments for vasospasm, including balloon
angioplasty and intraarterial vasodilators, decrease the
risk for infarction, but recurrent vasospasm remains a
complication [8,9]. Repeated vasospasm treatments have
been used as an outcome to compare endovascular res‐
cue treatments [8–10]. In a study examining 78 patients,
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Elliot et al. [10] found 42% of patients treated with an
intraarterial vasodilator, and 1% of patients treated with
balloon angioplasty required repeated treatment.
The study objective was to compare outcomes in those
suffering an aSAH before and after transitioning from
neurosurgery-led care in the intensive care unit (ICU), to
neurology-led multidisciplinary care in the neurocritical
care unit (NCCU). The study hypothesis was that neu‐
rology-led multidisciplinary care would improve patient
outcomes.
METHODS
This single-center retrospective cohort study was
approved by the Swedish Medical Center Institutional
Review Board with a waiver of patient consent. Inclu‐
sion criteria were: (1) ≥ 18 years old; (2) admitted to the
ICU between January 1, 2016 and August 31, 2016 (pre‐
group) or admitted to the NCCU between March 1, 2017
and November 31, 2017 (postgroup); and (3) for aSAH
treatment. Patients were identified by a positive angiog‐
raphy for nontraumatic aSAH. Data were collected from
NeuroBase (St. Augustine, FL); missing and additional
variables were abstracted by study personnel. Patients
were excluded if the SAH was not caused by an aneur‐
ysm or transfer patients who received care other than at
an outside facility’s emergency department.
The pregroup care was neurosurgery-led in the ICU with
16 beds dedicated to neurologic patients. A neurointen‐
sivist was available upon consult from January 1, 2016
through March 31, 2016 for pregroup care. The post‐
group care was a neurologist-led multidisciplinary
approach including a pulmonary intensivist, neurocriti‐
cal care clinical nurse specialist, and a neurosurgeon, in
an 18-bed NCCU. Furthermore, a euvolemia protocol
was implemented at the start of the postgroup time‐
frame.
All aSAH patients had permissive or pharmacologically
augmented blood pressure and daily transcranial Dop‐
pler ultrasound to monitor flow velocities and identify
vasospasm. Treatment decision was at the discretion of
the primary treating physician and the interventional
team. Common reasons for vasospasm treatment in the
IR included highly elevated flow velocities or new signs
of clinical deterioration. Vasospasm treatments included
balloon angioplasty and intraarterial vasodilator infu‐
sions.
The primary outcome was the number of trips to IR for
vasospasm treatment. Additional outcomes investigated
included hospital LOS, ICU/NCCU LOS, in-patient
ischemic stroke, mortality, discharge modified Rankin
Scale (mRS), and hospital discharge disposition. Mortal‐
ity included in-hospital mortality and hospital discharge
to hospice. Ischemic stroke etiologies were categorized
as vasospasm, procedural, vasospasm procedural, or
other. Demographic and clinical characteristics collected
were age, race, admission Hunt-Hess grade, admission
mRS, admission Fisher’s grade, pre-injury medications,
and comorbidities.
Descriptive data were expressed as means and standard
deviation, median and interquartile range, or propor‐
tions. Statistical differences were assessed using Fisher’s
exact test, Mann-Whitney U-test, Wilcoxon rank-sum
test, or chi-squared when appropriate. Multivariable
ordinal stepwise logistic regression and multivariable
stepwise logistic regression were used to determine if
outcomes were independently associated with a manage‐
ment approach. Data were analyzed using SAS 9.4
(Cary, NC) software, with an alpha value of 0.05.
RESULTS
The final study population consisted of 99 patients: 50
pregroup and 49 postgroup patients. Most patients
(65%) were female. Seventy-two percent of patients
were assigned an admission Hunt-Hess grade I–III, and
27% were assigned a grade of IV and V. Demographic
and clinical characteristic comparisons indicated the two
groups were similar, except that on average, postgroup
patients were seven (16) years older than pregroup
patients, (p = 0.05).
Most methods for treating aneurysms were not signifi‐
cantly different. Thirty-two (64%) pregroup and 32
(65%) postgroup patients had endovascular coiling. Five
(10%) pregroup and nine (18%) postgroup patients had
endovascular coiling with stent placement. Surgical clip‐
ping was done in five (10%) pregroup and three (6%)
postgroup patients. Seven (14%) pregroup and three
(6%) postgroup patients had a VP shunt placed. A pipe‐
line embolization device was placed in three (6%) pre‐
group and two (4%) postgroup patients. Three (6%) pre‐
group and three (6%) postgroup patients did not receive
definitive aneurysm treatment. An EVD was placed in
21 (47%) pregroup and 24 (53%) postgroup patients.
One (2%) pregroup and seven (14%) postgroup patients
had a hemicraniectomy (p = 0.03).
All LOSs were similar between groups. The pregroup’s
median hospital LOS was 18 days (8–28) and the post‐
group’s was 18 days (10–26), p = 0.27. Pregroup
patients had a median ICU LOS of 14 days (7–21); simi‐
larly, the postgroup’s was 14 days (10–18), p = 0.86.
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Discharge disposition remained comparable across study
arms. Two (5%) pregroup and five (14%) postgroup
patients were discharged to a skilled nursing facility. Fif‐
teen (38%) pregroup and fourteen (40%) postgroup
patients were discharged to acute rehabilitation. Finally,
22 (56%) pregroup and 16 (46%) postgroup patients
were discharged to home or home health.
Eighteen pregroup patients (36%) and 15 postgroup
patients (31%) developed an ischemic stroke. Of the
ischemic strokes, five (28%) pregroup and five (33%)
postgroup were vasospasm-caused. One (6%) pregroup
and one (7%) postgroup were vasospasm and procedur‐
ally-caused. Nine (50%) pregroup and four (27%) post‐
group were procedurally caused. Three (17%) pregroup
and five (33%) postgroup stroke etiologies were classi‐
fied as “other.” None of the differences seen were signif‐
icant. However, there was a significant decrease in
patients requiring repeated vasospasm treatment.
The odds were 62% lower that the postgroup had a
higher number of trips to IR for vasospasm treatment,
when compared to the pregroup, p < 0.001, seen in Table
1. After adjusting for age, the odds were 59% lower that
the postgroup had a higher number of trips to IR for vas‐
ospasm treatment when compared to the pregroup, p =
Table 1. Outcomes unadjusted and adjusted odds
ratios.
Outcome N (%) Postgroup
N = 49
Pregroup
N = 50
p
Vasospasm Treatments
   0
   1
   2
   3
   4
   5
   6
   7
   8
   OR (95% CI)
   AORa (95% CI)
75.51% (37)
6.12% (3)
6.12% (3)
8.16% (4)
4.08% (2)
0% (0)
0% (0)
0% (0)
0% (0)
0.38 (0.22, 0.66)
0.41 (0.23, 0.72)
74% (37)
8% (4)
4% (2)
2% (1)
2% (1)
0% (0)
2% (1)
4% (2)
4% (2)
Ref.
Ref.
0.46
<0.001
0.002
Vasospasmb
   OR (95% CI)
   AORc (95% CI)
13 (26.53%)
0.93 (0.34, 2.25)
1.32 (0.50, 3.55)
14 (28%)
Ref.
Ref.
>0.99
0.87
0.57
Ischemic stroke
   OR (95% CI)
   AORa (95% CI)
15 (30.61%)
0.78 (0.34, 1.81)
0.96 (0.40, 2.31)
18 (36%)
Ref.
Ref.
0.67
0.57
0.92
Discharge mRSd ≤ 2
   OR (95% CI)
   AORa (95% CI)
12 (24.49%)
0.62 (0.26, 1.51)
0.79 (0.31, 2.00)
17 (34%)
Ref.
Ref.
0.38
0.30
0.62
Mortalitye
   OR (95% CI)
   AORf (95% CI)
 
12 (28.57%)
1.42 (0.57, 3.53)
1.25 (0.38, 4.05)
 
11 (22%)
Ref.
Ref.
 
0.49
0.45
0.71
 
a: Adjusted for age;
b: patients who went to IR for vasospasm treatment or had an ischemic stroke caused by a
 vasospasm;
c: adjusted for age and sex;
d: mRS (favorable: 0–2, unfavorable: 3–6);
e: in-hospital mortality or discharge to hospice;
f: adjusted for Hunt and Hess (Favorable: 0–2 Unfavorable: 3–4);
 IR: interventional radiology; OR: odds ratio; AOR: adjusted odds ratio; CI: confidence
 interval; Ref: reference.
0.002. All other outcomes were comparable to the prior
neurosurgical-led care. There were 13 postgroup (27%)
and 14 pregroup patients (28%) with an angiography-
confirmed vasospasm. Twelve postgroup (29%) and 11
pregroup patients (22%) died in-hospital or were dis‐
charged to hospice. After adjustment for age, Hunt-
Hess, or sex, there were no significant differences
between groups for any other outcome.
DISCUSSION
The American Heart Association/American Stroke
Association (AHA/ASA) recommends aneurysm treat‐
ment determination to be made by a multidisciplinary
team but does not make any recommendations for pri‐
mary care service type [11]. This study suggests that
neurology-led multidisciplinary care can significantly
decrease the number of trips to IR for vasospasm treat‐
ment for aSAH patients while maintaining comparable
results to neurosurgical-led care. This is consistent with
previous research on aSAH management, which found
multidisciplinary care positively impacted LOS, dis‐
charge disposition, VP shunt placement, and discharge
mRS [1–3]. Multidisciplinary care is becoming more
common for neurocritical care patients.
In addition to the management change, the postgroup
treatment also included a euvolemia protocol, recom‐
mended by the AHA/ASA to prevent DCI [11].
Although the postgroup was treated with a euvolemia
protocol, our study did not find a significant change in
the number of in-patient ischemic strokes. However,
there was a significant decrease in the number of trips to
IR for vasospasm treatment. For many years, triple-H
protocols (hemodilution, hypervolemia, and hyperten‐
sion) have been used to treat vasospasms based on the
theory that they will increase arterial blood pressure and
cerebral brain flow through vasospastic arteries, but a
2010 literature review found there were sparse data to
support this theory, and that hypervolemia can lead to
volume overload [5,12]. Furthermore, the AHA/ASA
recommends not to use hypervolemia for vasospasm
prevention [12]. Another literature review conducted in
2014 recommended monitoring euvolemia instead of
hypervolemia for vasospasm prevention [13]. The multi‐
disciplinary approach facilitated the implementation of
the euvolemia protocol by the neurocritical care clinical
nurse specialist, which may have played a role in the
decreased number of trips to IR for vasospasm treat‐
ment.
This study has its limitations. The sample size was rela‐
tively small, which limited the number of confounders
32
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that could be controlled. Timing of IR treatments was
not collected; therefore, the ability to understand how
the number of trips to IR affects the risk of ischemic
stroke was limited. Furthermore, this study was a single-
center retrospective study and could not follow-up with
neurologic outcomes after hospital discharge.
CONCLUSIONS
In patients with aSAH, neurology-led multidisciplinary
care in the NCCU significantly decreased the odds of
repeated procedures for vasospasm treatment. Other out‐
comes were maintained comparable to the prior neuro‐
surgical-led care in the ICU. This decrease in repeated
IR procedures for vasospasm treatment undoubtedly
reduced the financial burden of hospitalization and low‐
ered the utilization of scarce hospital resources for
aSAH patients treated in the neurology-led multidiscipli‐
nary care group.
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